Cidara Therapeutics Stock Price History
| CDTX Stock | USD 20.40 2.95 16.91% |
Below is the normalized historical share price chart for Cidara Therapeutics extending back to April 14, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cidara Therapeutics stands at 20.40, as last reported on the 23rd of November, with the highest price reaching 21.28 and the lowest price hitting 17.52 during the day.
If you're considering investing in Cidara Stock, it is important to understand the factors that can impact its price. Cidara Therapeutics appears to be slightly risky, given 3 months investment horizon. Cidara Therapeutics secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19% return per unit of standard deviation over the last 3 months. By analyzing Cidara Therapeutics' technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk. Please makes use of Cidara Therapeutics' mean deviation of 2.65, and Risk Adjusted Performance of 0.1513 to double-check if our risk estimates are consistent with your expectations.
At this time, Cidara Therapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 71.9 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (7.8 M). . Price To Sales Ratio is likely to drop to 1.03 in 2024. Price Earnings Ratio is likely to drop to -3.18 in 2024. Cidara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of April 2015 | 200 Day MA 13.0169 | 50 Day MA 12.1246 | Beta 0.994 |
Cidara |
Sharpe Ratio = 0.1921
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CDTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.11 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.79 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average Cidara Therapeutics is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cidara Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.2432 | Enterprise Value Ebitda (1.64) | Price Sales 2.6685 | Shares Float 4.2 M | Wall Street Target Price 27.3333 |
Cidara Therapeutics Stock Price History Chart
There are several ways to analyze Cidara Stock price data. The simplest method is using a basic Cidara candlestick price chart, which shows Cidara Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 22, 2024 | 20.4 |
| Lowest Price | October 15, 2024 | 10.17 |
Cidara Therapeutics November 23, 2024 Stock Price Synopsis
Various analyses of Cidara Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cidara Stock. It can be used to describe the percentage change in the price of Cidara Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cidara Stock.| Cidara Therapeutics Price Rate Of Daily Change | 1.17 | |
| Cidara Therapeutics Price Action Indicator | 2.47 | |
| Cidara Therapeutics Price Daily Balance Of Power | 0.78 |
Cidara Therapeutics November 23, 2024 Stock Price Analysis
Cidara Stock Price History Data
The price series of Cidara Therapeutics for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 has a statistical range of 10.23 with a coefficient of variation of 14.43. The prices are distributed with arithmetic mean of 12.25. The median price for the last 90 days is 11.7. The company had 1:20 stock split on 24th of April 2024.| Open | High | Low | Close | Volume | ||
11/23/2024 | 17.73 | 21.28 | 17.52 | 20.40 | ||
| 11/22/2024 | 17.73 | 21.28 | 17.52 | 20.40 | 255,657 | |
| 11/21/2024 | 18.98 | 19.98 | 17.17 | 17.45 | 451,699 | |
| 11/20/2024 | 15.68 | 16.64 | 15.02 | 15.12 | 45,617 | |
| 11/19/2024 | 14.93 | 15.63 | 14.93 | 15.63 | 14,707 | |
| 11/18/2024 | 14.33 | 14.99 | 14.33 | 14.96 | 47,783 | |
| 11/15/2024 | 14.50 | 14.97 | 13.90 | 14.37 | 31,566 | |
| 11/14/2024 | 14.08 | 14.75 | 13.82 | 14.48 | 30,025 | |
| 11/13/2024 | 13.31 | 14.00 | 13.27 | 13.90 | 27,119 | |
| 11/12/2024 | 13.58 | 13.73 | 13.14 | 13.45 | 19,359 | |
| 11/11/2024 | 13.51 | 13.68 | 12.89 | 13.35 | 10,773 | |
| 11/08/2024 | 13.28 | 13.78 | 13.03 | 13.50 | 23,505 | |
| 11/07/2024 | 12.91 | 13.40 | 12.74 | 13.11 | 31,689 | |
| 11/06/2024 | 13.47 | 13.47 | 12.78 | 13.26 | 10,430 | |
| 11/05/2024 | 13.03 | 13.26 | 13.00 | 13.26 | 14,219 | |
| 11/04/2024 | 13.09 | 13.45 | 13.00 | 13.03 | 20,154 | |
| 11/01/2024 | 12.85 | 13.13 | 12.66 | 13.09 | 10,602 | |
| 10/31/2024 | 12.77 | 13.00 | 12.70 | 13.00 | 5,620 | |
| 10/30/2024 | 13.39 | 13.39 | 12.65 | 12.83 | 28,116 | |
| 10/29/2024 | 12.61 | 13.92 | 12.54 | 13.39 | 25,478 | |
| 10/28/2024 | 12.92 | 12.92 | 12.10 | 12.47 | 8,424 | |
| 10/25/2024 | 11.30 | 13.25 | 11.29 | 12.60 | 74,991 | |
| 10/24/2024 | 11.40 | 11.70 | 11.12 | 11.16 | 10,837 | |
| 10/23/2024 | 11.11 | 11.41 | 11.07 | 11.30 | 18,444 | |
| 10/22/2024 | 11.09 | 11.39 | 11.09 | 11.38 | 3,019 | |
| 10/21/2024 | 11.49 | 11.49 | 11.07 | 11.22 | 16,728 | |
| 10/18/2024 | 11.01 | 11.58 | 10.37 | 11.26 | 42,879 | |
| 10/17/2024 | 10.65 | 11.15 | 10.60 | 11.15 | 18,549 | |
| 10/16/2024 | 10.44 | 10.97 | 10.28 | 10.74 | 28,639 | |
| 10/15/2024 | 10.30 | 10.48 | 10.14 | 10.17 | 25,792 | |
| 10/14/2024 | 10.69 | 10.69 | 10.29 | 10.30 | 10,884 | |
| 10/11/2024 | 10.75 | 10.95 | 10.38 | 10.61 | 12,725 | |
| 10/10/2024 | 10.70 | 10.82 | 10.45 | 10.52 | 19,661 | |
| 10/09/2024 | 10.79 | 10.97 | 10.57 | 10.85 | 7,062 | |
| 10/08/2024 | 10.98 | 11.15 | 10.51 | 10.71 | 17,224 | |
| 10/07/2024 | 10.73 | 11.15 | 10.72 | 11.13 | 9,994 | |
| 10/04/2024 | 10.52 | 10.93 | 10.42 | 10.90 | 17,685 | |
| 10/03/2024 | 10.46 | 10.70 | 10.26 | 10.70 | 17,842 | |
| 10/02/2024 | 10.52 | 10.68 | 10.41 | 10.55 | 8,291 | |
| 10/01/2024 | 10.61 | 10.71 | 10.41 | 10.61 | 17,231 | |
| 09/30/2024 | 10.74 | 10.88 | 10.50 | 10.75 | 14,387 | |
| 09/27/2024 | 10.65 | 10.79 | 10.61 | 10.74 | 12,705 | |
| 09/26/2024 | 10.86 | 11.28 | 10.60 | 10.79 | 22,683 | |
| 09/25/2024 | 10.98 | 11.24 | 10.81 | 10.82 | 10,054 | |
| 09/24/2024 | 11.00 | 11.19 | 10.75 | 10.77 | 22,498 | |
| 09/23/2024 | 11.18 | 11.28 | 10.87 | 10.87 | 21,641 | |
| 09/20/2024 | 11.70 | 11.88 | 10.94 | 11.27 | 40,312 | |
| 09/19/2024 | 11.91 | 12.27 | 11.69 | 11.72 | 27,974 | |
| 09/18/2024 | 11.63 | 12.33 | 11.56 | 11.62 | 29,932 | |
| 09/17/2024 | 11.60 | 11.98 | 11.60 | 11.63 | 7,235 | |
| 09/16/2024 | 12.01 | 12.10 | 11.51 | 11.80 | 6,395 | |
| 09/13/2024 | 11.21 | 12.68 | 11.21 | 11.94 | 32,898 | |
| 09/12/2024 | 11.76 | 11.80 | 11.33 | 11.35 | 18,220 | |
| 09/11/2024 | 11.64 | 11.86 | 11.42 | 11.62 | 24,303 | |
| 09/10/2024 | 11.53 | 11.99 | 11.45 | 11.95 | 5,408 | |
| 09/09/2024 | 11.58 | 11.73 | 10.97 | 11.70 | 10,015 | |
| 09/06/2024 | 11.60 | 11.60 | 11.25 | 11.44 | 4,341 | |
| 09/05/2024 | 11.43 | 11.56 | 11.26 | 11.55 | 4,222 | |
| 09/04/2024 | 11.32 | 11.54 | 10.76 | 11.32 | 42,580 | |
| 09/03/2024 | 11.77 | 11.99 | 11.50 | 11.59 | 10,369 | |
| 08/30/2024 | 12.46 | 12.76 | 11.51 | 11.89 | 40,636 |
About Cidara Therapeutics Stock history
Cidara Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cidara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cidara Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cidara Therapeutics stock prices may prove useful in developing a viable investing in Cidara Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.4 M | 4.6 M | |
| Net Loss | -26.8 M | -28.2 M |
Cidara Therapeutics Stock Technical Analysis
Cidara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Cidara Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cidara Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cidara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cidara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1513 | |||
| Jensen Alpha | 0.6814 | |||
| Total Risk Alpha | 0.1094 | |||
| Sortino Ratio | 0.2596 | |||
| Treynor Ratio | 1.27 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cidara Stock Analysis
When running Cidara Therapeutics' price analysis, check to measure Cidara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cidara Therapeutics is operating at the current time. Most of Cidara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cidara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cidara Therapeutics' price. Additionally, you may evaluate how the addition of Cidara Therapeutics to your portfolios can decrease your overall portfolio volatility.